​

Aprea Therapeutics Ownership | Who Owns Aprea Therapeutics?

OverviewForecastRevenueFinancialsChart

Aprea Therapeutics Ownership Summary

Aprea Therapeutics is owned by 17.74% institutional investors, 11.56% insiders, and 70.71% retail investors. Aigh capital management is the largest institutional shareholder, holding 15.53% of APRE shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.67% of its assets in Aprea Therapeutics shares.

APRE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAprea Therapeutics17.74%11.56%70.71%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Aigh capital management1.02M15.53%$774.76K
Vestal point capital, lp350.00K5.35%$267.01K
Sphera funds management270.00K4.13%$205.98K
Nantahala capital management205.76K3.15%$156.97K
Dafna capital management137.17K2.25%$202.33K
Sio capital management112.22K1.84%$165.53K
Geode capital management119.13K1.82%$90.89K
Scientech research60.28K0.92%$45.99K
Vanguard group58.09K0.91%$49.55K
Bnp paribas arbitrage, snc39.82K0.61%$30.38K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aigh capital management1.02M0.11%$774.76K
Dafna capital management137.17K0.05%$202.33K
Sio capital management112.22K0.04%$165.53K
Scientech research60.28K0.04%$45.99K
Sphera funds management270.00K0.03%$205.98K
Vestal point capital, lp350.00K0.01%$267.01K
Nantahala capital management205.76K0.01%$156.97K
Two sigma securities13.50K0.00%$10.30K
Tower research capital llc (trc)5.13K0.00%$3.91K
Wealthcollab158.00-$121.00

Top Buyers

HolderShares% AssetsChange
Aigh capital management1.02M0.11%645.00K
Vestal point capital, lp350.00K0.01%350.00K
Geode capital management119.13K-78.18K
Scientech research60.28K0.04%60.28K
Vanguard fiduciary trust38.46K-38.46K

Top Sellers

HolderShares% AssetsChange
Murchinson---340.14K
Sio capital management112.22K0.04%-167.15K
Drw securities---120.65K
Stonepine capital management---102.24K
Vanguard group58.09K--100.15K

New Positions

HolderShares% AssetsChangeValue
Vestal point capital, lp350.00K0.01%350.00K$267.01K
Scientech research60.28K0.04%60.28K$45.99K
Vanguard fiduciary trust38.46K-38.46K$29.35K
Renaissance25.10K-25.10K$19.15K
Two sigma securities13.50K0.00%13.50K$10.30K

Sold Out

HolderChange
Citigroup-5.00
Jpmorgan chase-10.00
Princeton global asset management-100.00
Fmr-501.00
Mb, levis & associates-806.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202611-50.00%1,159,768-31.60%172.51%5-50.00%2-66.67%
Dec 31, 202515-34.78%998,602-38.31%152.21%6-14.29%4-33.33%
Sep 30, 202523-1,618,851-10.83%262.99%7-12.50%650.00%
Jun 30, 202523-11.54%1,815,208-6.90%292.82%740.00%4-42.86%
Mar 31, 202526-1,949,704-6.15%322.29%5-50.00%775.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF145.28K2.67%-
Vanguard Total Stock Mkt Idx Inv142.17K2.57%-3.11K
Fidelity Extended Market Index101.79K0.82%30.67K
Vanguard Institutional Extnd Mkt Idx Tr19.62K0.24%-
DFA US Targeted Value I7.98K0.14%-
Dimensional US Targeted Value ETF3.52K0.06%-
Fidelity Total Market Index7.20K0.06%-
Spartan Extended Market Index Pool E2.95K0.05%212.00
Fidelity Series Total Market Index5.85K0.05%-
DFA US Core Equity 1 I2.19K0.04%-

Recent Insider Transactions

DateNameRoleActivityValue
Mar 31, 2026Hamill John P. SrVP/CFO/Prin Fin & Acct OfcrBuy$30.98
Mar 31, 2026Hamill John P. SrVP/CFO/Prin Fin & Acct OfcrBuy$21.16K
Mar 31, 2026Peters Richard-Buy$84.63K
Mar 31, 2026Peters Richard-Buy$123.92
Jan 30, 2026Gilad Oren President/CEOBuy$25.01K

Insider Transactions Trends

DateBuySell
2026 Q18-
2025 Q46-
2025 Q22-
2025 Q1--
2024 Q491

APRE Ownership FAQ

Who Owns Aprea Therapeutics?

Aprea Therapeutics shareholders are primarily institutional investors at 17.74%, followed by 11.56% insiders and 70.70% retail investors. The average institutional ownership in Aprea Therapeutics's industry, Biotech Stocks , is 35.75%, which Aprea Therapeutics falls below.

Who owns the most shares of Aprea Therapeutics?

Aprea Therapeutics’s largest shareholders are Aigh capital management (1.02M shares, 15.53%), Vestal point capital, lp (350K shares, 5.35%), and Sphera funds management (270K shares, 4.13%). Together, they hold 25.01% of Aprea Therapeutics’s total shares outstanding.

Does Blackrock own Aprea Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aprea Therapeutics.

Who is Aprea Therapeutics’s biggest shareholder by percentage of total assets invested?

Aigh capital management is Aprea Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.11% of its assets in 1.02M Aprea Therapeutics shares, valued at 774.76K$.

Who is the top mutual fund holder of Aprea Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Aprea Therapeutics shares, with 2.67% of its total shares outstanding invested in 145.28K Aprea Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools